Abbot Reports Robust Growth in Pharmaceutical and Nutritional Sales in 2024
Karachi: Abbot has released its un-audited condensed interim financial statements for the nine months ending September 30, 2024, showcasing a significant 20% increase in overall sales compared to the same period last year. According to information ava…